UTK Special 1/12/26
Bregman Signs
The Cubs didn’t stumble into this deal. Five years, $175 million for Alex Bregman, covering ages 31 through 35, is not the act of a naïve front office chasing name value. Chicago has one of the more analytically mature organizations in baseball, a medical staff that’s been steadily modernized, and a track record of leaning into sports science earlier than most. If they signed off on this, they did it with eyes open.
That doesn’t mean the risk goes away.
Bregman’s résumé is easy to like. He’s been consistently productive, his offensive game is built more on strike-zone control and contact quality than raw athleticism, and he’s never relied on elite speed. Those are the kinds of traits teams want to see when betting on a player’s thirties. From a pure baseball standpoint, this is defensible.
From an injury standpoint, it’s complicated.
Bregman’s history isn’t catastrophic, but it’s meaningful. Bone spurs in the elbow are rarely isolated events. They’re usually the result of accumulated stress, especially in infielders who throw hard and often. You can manage them. You can scope them. What you can’t do is erase the underlying signal. Add last season’s significant quad strain and now you’re talking about two different systems, upper and lower, both flagging as potential future constraints rather than past problems.
That matters because third base is a young man’s position. Reaction time, lateral burst, and lower-half durability all erode with age. When third basemen lose a step, they don’t just lose defensive value. They lose margin for error everywhere. Fewer balls become outs. More stress goes onto the arm. Small injuries linger longer. The position amplifies decline. Bregman was initially moved there for need - Carlos Correa locked down short and Bregman’s made the transition look good. He could easily move to second if needed and the DH position is there if the legs get more problematic.
We’ve seen this movie before. Eric Chavez looked like a perfect aging candidate entering his thirties. Elite glove, strong on-base skills, high baseball IQ. From age 31 on, he was worth less than three total wins. Back and shoulder issues turned a gentle slope into a cliff. He didn’t forget how to play. His body just stopped cooperating.
The extreme downside is Anthony Rendon, who went from franchise cornerstone to near-total absence. Rendon is the outlier, not the expectation, but ignoring that tail of the distribution is how teams end up shocked by outcomes they should have modeled. The Cubs aren’t the Angels, so I think this risk is near-zero.
There are better paths, too. Robin Ventura produced nearly 17 wins from ages 31 to 35 by staying functional, adjusting his game, and avoiding cascading injuries. Gary Gaetti remained a positive contributor into his late thirties, with roughly 11.5 wins over the same age window the Cubs just purchased. Those careers weren’t about stardom. They were about availability, adaptability, and controlled decline.
This is where the Cubs deserve credit. They are not guessing. They have biomechanical data, workload tracking, recovery modeling, and medical oversight that far exceeds what teams had when Chavez or Gaetti were making their aging journeys. If any organization believes it can manage the elbow, protect the lower half, and modulate defensive demands to stretch Bregman’s usefulness, it’s one like Chicago.
But medicine doesn’t eliminate aging. It only slows it and sometimes only slightly.
This deal isn’t about whether Bregman can perform in year one or even year two. He almost certainly can. It’s about whether the Cubs can keep him on the field, structurally intact, through the back half of the contract when third base becomes less forgiving and injuries stop being discrete events and start becoming patterns.
The Cubs aren’t stupid. They made an informed deal at market price when many teams aren’t even trying. The question isn’t whether the logic was sound. It’s whether the biology cooperates.
The slow market continues to frustrate everyone I speak to inside the game, with blame descending into the standard finger pointing. Agents blame teams, team blame agents, but there’s surprise amongst players that no team is pushing for “win now” and “bold move” kind of signings. One player I spoke with who was a free agent recently said that while he had multiple early offers, they were all very much the same. “They all use the same projection systems and the only difference is really need and bias,” he explained. “It’s not like the draft where one scout can push for a player. It’s two or three guys, plus ownership setting an overall payroll number.”
Even in situations where it turns into a bit of a recruiting format, selling the player on the team’s situation, the location, and secondary opportunities, those are roughly the same as well. “What did they tell me that I didn’t know?” said the same player. “I knew what they had coming, who’d be going, things like that. I could talk to a friend on the team about the culture, the expectations. Most clubs have a ‘wives chat’ that gets involved a bit, but I’m not married so I can’t tell you as much about that.”
With Kyle Tucker, Bo Bichette, and Cody Bellinger all available on the player side, and Framber Valdez and Ranger Suarez leading the pitcher side, one agent told me that those have to move before the secondaries come in. “All the Plan B options have to wait, see who doesn’t get their guy,” he explained. He thought that the Bregman signing might loosen up the market for someone like Eugenio Suarez, but for most the offers simply aren’t there.
One example he gave was Zac Gallen, who was close to a deal with the Cubs before they elected to trade for Edward Cabrera instead. While there would seem to be budget for him in many places, reports have Gallen getting short term offers, down to a voidable two year deal to keep the compensation pick lower. I won’t go into all the technical details of comp picks, but there is a weight there and Bregman’s deals the last two years show the cost to players in movement.
Two agents pointed to JT Realmuto as a surprise. “He’s durable, he’s 34, and what other options do the Phillies have? If they’re bringing almost everyone back from a good team, how does losing Realmuto make them as good? [Rafael] Marchan isn’t the guy. [Garrett] Stubbs isn’t the guy. There’s no one else on the market so even if they’re waiting on Bichette, waiting on Suarez, the Phils should already have Realmuto locked up and I bet [Bryce] Harper is hot about it.”
One of those agents is also surprised that the Giants aren’t more active. “If [the Giants] aren’t even in on one of these big remaining guys, what are they doing? The [Rafael] Devers deal fell in their lap, credit for getting it done, but what else is Buster [Posey] doing to make that team better? You don’t hire a college coach [Tony Vitello] and wait on player development. Buster’s made no statement move and that team’s not beating the Dodgers.”
Max Kepler was hit with an 80-game suspension as the result of an off-season drug test coming back positive for metabolites of trenbolone, a drug with a two to three month detectable period. Why would Kepler, a free agent, be using in the offseason? Trenbolone is often cited as a “good trainer”, enabling harder workouts, putting on muscle density versus muscle mass, but it’s seldom used in baseball - no positive tests since the joint program began in 2005 - because it’s so easily detected.
Kepler has yet to offer any explanation, though it’s use in cattle offers up the “Mexican meat” excuse used by some, though the specific metabolite and the advanced testing used by MLB’s program make fighting it a very uphill battle for Kepler if he chooses to fight. As he’s not signed, but was in active negotiations with at least one team, it’s likely that baseball will allow him to serve his suspension even if he doesn’t have a contract. He would be ineligible for the ‘26 playoffs, but could return once the signing team has played at least 80 games this season.
A reminder: I will be on the road a LOT over the next couple weeks. I’ll be speaking to MLB medical staffs on Friday (and yes, I’ll post it here in some format) and then I’m off to the Caribbean for 10 days. Anyone have good tips for San Juan, Puerto Rico? I have some pieces loaded up to fill the gap, but breaking news will happen and I’m not taking the MacBook with me. When I get back, big announcement.
The Cubs should hope Bregman is Mike Schmidt Jr. Schmidt played 3B above league average into his late 30s.